Stringent restrictions have been imposed while further testing takes place, including a ban on fish movement in the area.
Pancreatic disease (PD) has been detected at two salmon farming sites operated by Mowi in Alstahaug municipality, Norway.
These sites, 10447 Mefaldskjæret and 31857 Blomsøråsa, fall within a protection zone that was established following the detection of PD at site 45003 Ystøya in September earlier this year.
To prevent potential disease transmission, stringent restrictions have been imposed, including a ban on fish movement in the area, as emphasized by the Norwegian Food Safety Authority.
Mowi reported its suspicion of PD on November 16 after obtaining positive analysis results from its internal tests. Over the coming days, the Norwegian Food Safety Authority intends to gather additional samples for analysis at the Veterinary Institute.
Geir Arne Ystmark, regional director of the Norwegian Food Safety Authority commented, “Should the Veterinary Institute’s analyses confirm the presence of PD at these locations, we will make a decision to swiftly cull the fish, as these sites are in an area where PD must be combated to prevent its establishment.”
The Norwegian Food Safety Authority is also considering potential adjustments to the size of the established restriction zone.
PD is a viral disease that significantly impacts the health and well-being of salmon. Infected fish experience reduced appetite, slow growth, and increased mortality, rendering them more vulnerable to other diseases. While PD poses no threat to human health, it is crucial to prevent further infections in other aquaculture facilities.
Pancreas disease: Site with 900,000 salmon could be culled to stop spread of the contagion
